The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
The Disease Activity Score and the EULAR Response Criteria
Abstract
\n Contains fulltext :\n 81347.pdf (Publisher’s version ) (Closed access)\n
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevoo, M. L. L., Van'T Hof, M. A., Kuper, H. H., Van Leeuwen, M. A., Van De Putte, L. B. A., & Van Riel, P. L. C. M. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380107 · Cited by 6,243
Self-citationAmerican college of rheumatology preliminary definition of improvement in rheumatoid arthritis
Felson, D. T., Anderson, J. J., Boers, M., Bombardier, C., Furst, D., Goldsmith, C., Katz, L. M., Lightfoot, R., Paulus, H., Strand, V., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380602 · Cited by 2,829
Felson, D. T., Anderson, J. J., Boers, M., Bombardier, C., Chernoff, M., Fried, B., Furst, D., Goldsmith, C., Kieszak, S., Lightfoot, R., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780360601 · Cited by 1,640
van Gestel, A. M., Prevoo, M. L. L., van't Hof, M. A., van Rijswijk, M. H., van de Putte, L. B. A., & van Riel, P. L. C. M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390105 · Cited by 1,572
Self-citationGrigor, C., Capell, H., Stirling, A., McMahon, A. D., Lock, P., Vallance, R., Porter, D., & Kincaid, W. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16676-2 · Cited by 1,435
Saag, K. G., Teng, G. G., Patkar, N. M., Anuntiyo, J., Finney, C., Curtis, J. R., Paulus, H. E., Mudano, A., Pisu, M., Elkins‐Melton, M., et al. (2008) · Arthritis Care & Research · doi:10.1002/art.23721 · Cited by 1,157
van der Heijde, D. M., van 't Hof, M. A., van Riel, P. L., Theunisse, L. A., Lubberts, E. W., van Leeuwen, M. A., van Rijswijk, M. H., & van de Putte, L. B. (1990) · Annals of the Rheumatic Diseases · doi:10.1136/ard.49.11.916 · Cited by 1,087
Self-citationAletaha, D., & Smolen, J. S. (2005) · PubMed · Cited by 843
Validation of rheumatoid arthritis improvement criteria that include simplified joint counts
van Gestel, A. M., Haagsma, C. J., & van Riel, P. L. C. M. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199810)41:10<1845::aid-art17>3.0.co;2-k · Cited by 803
Self-citationDevelopment of a disease activity score based on judgment in clinical practice by rheumatologists.
van der Heijde, D. M. F. M., Hof, M. V. '., van Riel, P. L., & van de Putte, L. B. (1993) · PubMed · Cited by 787
Research works printed but not linked: 9
- Van Gestel, 1999, ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials, J Rheumatol, 26, 705
- Fransen, 2005, The effectiveness of systematic monitoring of RA disease activity in daily practice (TRAC): a multi centre, cluster-randomised controlled trial, Ann Rheum Dis, 64, 1294, 10.1136/ard.2004.030924 · doi:10.1136/ard.2004.030924
- Fransen, 2005, The Disease Activity Score and the EULAR response criteria, Clin Exp Rheumatol, 23, S93
- Wolfe, 2001, Consensus recommendations for the assessment and treatment of rheumatoid arthritis, J Rheumatol, 28, 1413
- Fransen, 2002, The merits of monitoring: should we follow all our rheumatoid arthritis patients in daily practice?, Rheumatology (Oxford), 41, 601, 10.1093/rheumatology/41.6.601 · doi:10.1093/rheumatology/41.6.601
- Farrant, 2007, Advanced imaging in rheumatoid arthritis. Part 1: synovitis, Skeletal Radiol, 36, 269, 10.1007/s00256-006-0219-9 · doi:10.1007/s00256-006-0219-9
- Farrant, 2007, Advanced imaging in rheumatoid arthritis: part 2: erosions, Skeletal Radiol, 36, 381, 10.1007/s00256-006-0220-3 · doi:10.1007/s00256-006-0220-3
- Boers, 1993, The validity of pooled outcome measures (indices) in rheumatoid arthritis clinical trials, J Rheumatol, 20, 568
- Van der Heijde, 1998, The original DAS and the DAS28 are not interchangeable: comment on the articles by Prevoo et al, Arthritis Rheum, 41, 942, 10.1002/1529-0131(199805)41:5<942::AID-ART26>3.0.CO;2-B · doi:10.1002/1529-0131(199805)41:5<942::aid-art26>3.0.co;2-b
Cited by
Koopman, F. A., Chavan, S. S., Miljko, S., Grazio, S., Sokolovic, S., Schuurman, P. R., Mehta, A. D., Levine, Y. A., Faltys, M., Zitnik, R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605635113 · Cited by 1,024
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
van Vollenhoven, R. F., Fleischmann, R., Cohen, S., Lee, E. B., García Meijide, J. A., Wagner, S., Forejtova, S., Zwillich, S. H., Gruben, D., Koncz, T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112072 · Cited by 945
Wells, G., Becker, J.-C., Teng, J., Dougados, M., Schiff, M., Smolen, J., Aletaha, D., & van Riel, P. L. C. M. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.084459 · Cited by 878
Self-citationJones, G., Sebba, A., Gu, J., Lowenstein, M. B., Calvo, A., Gomez-Reino, J. J., Siri, D. A., Tomšič, M., Alecock, E., Woodworth, T., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.105197 · Cited by 797
Schiff, M., Keiserman, M., Codding, C., Songcharoen, S., Berman, A., Nayiager, S., Saldate, C., Li, T., Aranda, R., Becker, J.-C., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.080002 · Cited by 539
Pucino, V., Certo, M., Bulusu, V., Cucchi, D., Goldmann, K., Pontarini, E., Haas, R., Smith, J., Headland, S. E., Blighe, K., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.10.004 · Cited by 530
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
Singh, J. A., Christensen, R., Wells, G. A., Suarez-Almazor, M. E., Buchbinder, R., Lopez-Olivo, M. A., Ghogomu, E. T., & Tugwell, P. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007848.pub2 · Cited by 470
PINCUS, T., SWEARINGEN, C. J., BERGMAN, M., & YAZICI, Y. (2008) · The Journal of Rheumatology · doi:10.3899/jrheum.080182 · Cited by 349
McInnes, I. B., Sieper, J., Braun, J., Emery, P., van der Heijde, D., Isaacs, J. D., Dahmen, G., Wollenhaupt, J., Schulze-Koops, H., Kogan, J., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202646 · Cited by 343
Kremer, J. M., Cohen, S., Wilkinson, B. E., Connell, C. A., French, J. L., Gomez‐Reino, J., Gruben, D., Kanik, K. S., Krishnaswami, S., Pascual‐Ramos, V., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33419 · Cited by 344
Anakinra for Rheumatoid Arthritis: A Systematic Review
MERTENS, M., & SINGH, J. A. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090074 · Cited by 344
Understanding uveitis: The impact of research on visual outcomes
de Smet, M. D., Taylor, S. R. J., Bodaghi, B., Miserocchi, E., Murray, P. I., Pleyer, U., Zierhut, M., Barisani-Asenbauer, T., LeHoang, P., & Lightman, S. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.06.005 · Cited by 340
Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis
Rubbert-Roth, A., Enejosa, J., Pangan, A. L., Haraoui, B., Rischmueller, M., Khan, N., Zhang, Y., Martin, N., & Xavier, R. M. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2008250 · Cited by 298
Malottki, K., Barton, P., Tsourapas, A., Uthman, A., Liu, Z., Routh, K., Connock, M., Jobanputra, P., Moore, D., Fry-Smith, A., et al. (2011) · Health Technology Assessment · doi:10.3310/hta15140 · Cited by 287
Keystone, E. C., Taylor, P. C., Drescher, E., Schlichting, D. E., Beattie, S. D., Berclaz, P.-Y., Lee, C. H., Fidelus-Gort, R. K., Luchi, M. E., Rooney, T. P., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206478 · Cited by 281
Anderson, J. K., Zimmerman, L., Caplan, L., & Michaud, K. (2011) · Arthritis Care & Research · doi:10.1002/acr.20621 · Cited by 260
Mechanistic biomarkers for clinical decision making in rheumatic diseases
Robinson, W. H., Lindstrom, T. M., Cheung, R. K., & Sokolove, J. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.14 · Cited by 109
Yoosuf, N., Maciejewski, M., Ziemek, D., Jelinsky, S. A., Folkersen, L., Müller, M., Sahlström, P., Vivar, N., Catrina, A., Berg, L., et al. (2022) · Rheumatology · doi:10.1093/rheumatology/keab521 · Cited by 64
Response to biologic drugs in patients with rheumatoid arthritis and antidrug antibodies
Bitoun, S., Hässler, S., Ternant, D., Szely, N., Gleizes, A., Richez, C., Soubrier, M., Avouac, J., Brocq, O., Sellam, J., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.23098 · Cited by 43
Bouget, V., Duquesne, J., Hassler, S., Cournède, P.-H., Fautrel, B., Guillemin, F., Pallardy, M., Broët, P., Mariette, X., & Bitoun, S. (2022) · RMD Open · doi:10.1136/rmdopen-2022-002442 · Cited by 29
Methylglyoxal: A Relevant Marker of Disease Activity in Patients with Rheumatoid Arthritis
Knani, I., Bouzidi, H., Zrour, S., Bergaoui, N., Hammami, M., & Kerkeni, M. (2018) · Disease Markers · doi:10.1155/2018/8735926 · Cited by 25
“Disease activity was used to assess the disease activity score for 28 joints (DAS28 score) according to EULAR’s recommendations [18].”
MethodJulià, A., Gómez, A., López-Lasanta, M., Blanco, F., Erra, A., Fernández-Nebro, A., Mas, A. J., Pérez-García, C., Vivar, M. L. G., Sánchez-Fernández, S., et al. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.104053 · Cited by 24
Reduced corticosteroid‐binding globulin cleavage in active rheumatoid arthritis
Nenke, M. A., Lewis, J. G., Rankin, W., McWilliams, L., Metcalf, R. G., Proudman, S. M., & Torpy, D. J. (2016) · Clinical Endocrinology · doi:10.1111/cen.13081 · Cited by 13
Ziade, N., Arayssi, T., Elzorkany, B., Daher, A., Karam, G. A., Jbara, M. A., Aiko, A., Alam, E., Emadi, S. A., Mashaleh, M. A., et al. (2021) · Mediterranean Journal of Rheumatology · doi:10.31138/mjr.32.1.66 · Cited by 12
Metadata
- Authors
- Fransen, J., & van Riel, P. L. C. M.
- Venue
- Rheumatic Disease Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 35
- Issue
- 4
- Pages
- 745-757
- ISSN
- 0889-857X
- OpenAlex
- W2001917088
- Cited by
- 877
- References
- 34
- FWCI
- 23.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.